Attached files
| file | filename |
|---|---|
| EX-99.1 - ERBA Diagnostics, Inc. | v193990_ex99-1.htm |
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
_________________________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
_________________________________
Date of
Report
August 16,
2010
(Date of
earliest event reported)
IVAX Diagnostics,
Inc.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
1-14798
|
11-3500746
|
||
|
(State
or other jurisdiction of
incorporation
or organization)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
||
|
2140
North Miami Avenue
Miami, Florida
|
33127
(Zip
Code)
|
|||
|
(Address
of principal executive offices)
|
(305)
324-2300
(Registrant’s
telephone number, including area code)
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
o Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
o Pre-commencement
communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02
|
Results
of Operations and Financial
Condition.
|
On August 16, 2010, the registrant
issued a press release announcing its financial results for the quarter ended
June 30, 2010. A copy of the press release is being furnished as
Exhibit 99.1 to this Current Report on Form 8-K.
The information in this Current Report
on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 2.02 and
shall not be deemed to be “filed” for purposes of Section 18 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to
the liabilities of that section, nor shall it be deemed to be incorporated by
reference in any filing under the Securities Act of 1933, as amended, or the
Exchange Act.
|
Item
9.01
|
Financial
Statements and Exhibits.
|
|
(d)
|
Exhibit
99.1 - Press Release dated August 16,
2010
|
2
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
|
IVAX
DIAGNOSTICS, INC.
|
|||
|
|
By:
|
/s/ Arthur R. Levine | |
| Arthur R. Levine | |||
| Chief Financial Officer | |||
Dated: August
16, 2010
EXHIBIT
INDEX
| Exhibit | Description |
| 99.1 | Press Release dated August 16, 2010 |